Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.2, replacing Revision: v3.3.1. No study content or critical functionality is affected.
    Difference
    0.0%
    Check dated 2025-11-28T00:35:56.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. No visible changes to study content, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2025-11-20T23:00:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page. It now displays only the study details and related information.
    Difference
    0.3%
    Check dated 2025-11-13T17:06:40.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. Any differences appear cosmetic or layout-related and do not affect core study details such as eligibility, interventions, or outcomes.
    Difference
    0.4%
    Check dated 2025-10-30T11:33:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Added: Revision: v3.2.0 update badge. - Removed: Ovarian cancer resource under Genetic and Rare Diseases Information Center topics, and removal of Revision: v3.0.2.
    Difference
    0.3%
    Check dated 2025-10-01T04:51:35.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added v3.1.0; removed the Ovarian cancer resource and the v3.0.2 revision.
    Difference
    0.3%
    Check dated 2025-09-30T03:45:19.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.